Stratagen Bio
The Future of MRI
Cambridge, United States · Founded 2019 · $5.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- stratagenbio.com
- Total Funding
- $5.0M
- Last Round
- $5.0M SeedJun 2026
- Rounds
- 1
About
Stratagen Bio is a Harvard-based life sciences company transforming MRI into a platform for quantitative biomarker assessment and objective clinical decision-making. Founded by Gregory Ekchian (CEO) and Professor Michael Cima, the company enhances existing MRI hardware to yield precise quantitative tissue measurements enabling more in-depth, objective data on tissue health without requiring new scanner infrastructure. The approach is especially valuable for detecting and treating cancer, neurological conditions, and muscular pathologies. Stratagen Bio is a resident of the Pagliuca Harvard Life Lab and was a Grand Prize winner of the 2024 Harvard President's Innovation Challenge.
Summary
Stratagen Bio is a Healthcare company based in Cambridge, United States, founded in 2019. It has raised $5.0M in total across 1 round, most recently a $5.0M Seed round in Jun 2026.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2026
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...